Quantcast
Last updated on April 17, 2014 at 14:37 EDT

Latest Alzheimer's Drug Discovery Foundation Stories

2014-01-28 08:30:32

NEW YORK, Jan. 28, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation of Canada (ADDF-Canada) and The W. Garfield Weston Foundation today announced a new funding collaboration to support a clinical trial investigating the potential for hypertension drugs to slow Alzheimer's disease progression. The trial will be led by Dr. Sandra Black and the Toronto Dementia Research Alliance at the University of Toronto. (Logo:...

2014-01-24 08:24:25

Research to Focus on Repurposing Drugs for Alzheimer's Disease and Related Dementias NEW YORK, Jan. 24, 2014 /PRNewswire-USNewswire/ -- Today the Alzheimer's Drug Discovery Foundation (ADDF) and the Alzheimer's Society (UK) announced a new partnership that will provide funding for research in Alzheimer's disease and related dementias, with the goal of accelerating critical development programs and bringing new treatments to patients. The partnership intends to fund projects up to $1.5...

2013-12-05 12:29:27

NEW YORK, Dec. 5, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) presents its annual winter conference, the 8(th) Annual Drug Discover for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs, taking place on February 2-4, 2014 at the Miami Beach Resort in Miami, Florida. (Logo: http://photos.prnewswire.com/prnh/20130909/DC75486LOGO) Designed as a comprehensive course on the drug discovery process, from target...

2013-11-06 08:30:52

NEW YORK, Nov. 6, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced yesterday the launch of its newly expanded ADDF ACCESS program to provide scientists in academia and small biotechnology companies with access to a virtual network of drug discovery experts and contract research organizations (CROs) that have experience developing therapies for neurodegenerative diseases. Through the effective selection of CROs and use of their services,...

2013-10-24 12:26:13

Partnership increases critical support for researchers' efforts to find new therapies to treat Alzheimer's disease CLEVELAND, Oct. 24, 2013 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals (UH) Case Medical Center announced today a newly formed partnership that will leverage their combined expertise and resources to advance highly promising Alzheimer's disease drug discovery projects conducted in academic...

2013-10-24 12:24:37

What for? To honor his father, New York Giants Running Back, Ron Johnson, diagnosed in 2008 with early-onset Alzheimer's disease... NEW YORK, Oct. 24, 2013 /PRNewswire-USNewswire/ -- This is one story of a runner with a reason. Thirty-one year old Chris Johnson, son of legendary New York Giants Running Back, Ron Johnson has taken up the cause to find the prevention, treatment and ultimately cure for a disease that once upon a time was as mysterious and taboo as cancer used to be....

2013-09-10 08:31:33

NEW YORK, Sept. 10, 2013 /PRNewswire-USNewswire/ -- The fashion world's power players are often on the front lines supporting, advocating and raising awareness for many philanthropic, charitable and scientific causes. It is their incredible star wattage that draws attention from the media and raises awareness in the community. During this World Alzheimer's Month, celebrity designer Patricia Gomez-Gracia steps up to add her star power and creative talent to benefit the Alzheimer's...

2013-09-09 08:28:18

NEW YORK, Sept. 9, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) will host Hope on the Horizon: New Drugs for Alzheimer's Disease. The luncheon and symposium will honor Liz and Randal Sandler with the Charles Evans Award for their longtime commitment to the Alzheimer's community. (Logo: http://photos.prnewswire.com/prnh/20130909/DC75486LOGO ) The event, hosted by Paula Zahn, Norah O'Donnell, and chaired by Leonard A. Lauder, ADDF co-founder and chairman,...

2013-08-20 12:26:57

NEW YORK, Aug. 20, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) presents its annual fall conference, the 14th International Conference on Alzheimer's Drug Discovery taking place on September 9-10, 2013 at the Hyatt Regency in Jersey City, NJ, across the Hudson River from New York City. This annual conference brings together academic and industry scientists conducting drug discovery and development for Alzheimer's disease and related dementias. The...

2013-07-01 12:28:08

Optimizing the Use of CROs to Accelerate Preclinical Drug Discovery NEW YORK, July 1, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today launched the ADDF ACCESS program to give the academic and small biotechnology communities online access to a marketplace of contract research organizations (CROs) and the industry standard preclinical drug discovery and development services they provide. Additionally, ADDF ACCESS offers educational resources and...